Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
本发明涉及新型化合物。该化合物通常包含一个酸性基团、一个碱性基团、一个取代的
氨基或N-酰基和一个具有可选羟基化的烷基部分。本发明还涉及包含所述
抑制剂的制药组合物。还描述了用于抑制怀疑含有
神经氨酸酶的样品中
神经氨酸酶的方法。还描述了抗原材料、
聚合物、
抗体、标记化合物的结合物以及用于检测
神经氨酸酶活性的测定方法。